{"transactions":[{"id":746623,"issuer":{"id":4369,"kind":"organization","name":"Sunshine Silver Mining & Refining Co"},"owners":[{"id":40605,"kind":"organization","name":"Ospraie Real Assets Fund LP","position":1,"cik":"0001983637","reported_name":"Ospraie Real Assets Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40606,"kind":"organization","name":"Ospraie Real Assets GP LLC","position":2,"cik":"0002126039","reported_name":"Ospraie Real Assets GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":3,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":4,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":5,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":6,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2026-06-08T23:58:44.000Z","date":"2026-06-05","kind":"other","planned":false,"acquired":true,"shares":2615060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The warrant is exercisable until September 2, 2027; provided, that the warrant shall automatically be deemed to be exercised, on a cashless exercise basis, as to all shares of common stock of the Issuer for which it shall not previously have been exercised, upon the closing of an initial public offering by the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Ospraie Management, LLC (\"OM LLC\") is the investment manager of ORA Fund and has been delegated voting and investment power and thus beneficial ownership of the securities of the Issuer held by ORA Fund. Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the securities of the Issuer held by ORA Fund as the managing member of OM LLC. Ospraie Management, Inc. (\"OM Inc.\") may be deemed to beneficially own the securities of the Issuer held by ORA Fund as the general partner of Ospraie Holding."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Ospraie Real Assets GP LLC (\"Ospraie GP\") may be deemed to beneficially own the securities of the Issuer held by ORA Fund as the general partner of ORA Fund. Dwight Anderson may be deemed to beneficially own the securities of the Issuer held by ORA Fund as the managing member of Ospraie GP and as the sole owner of OM Inc. Each reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":2.87,"exercise_date":"2022-09-02","underlying":"Common Stock","underlying_shares":2615060},"source":{"system":"sec-edgar","filing":"0001213900-26-066476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2091017/000121390026066476/ownership.xml","form_type":"4"}},{"id":746622,"issuer":{"id":4369,"kind":"organization","name":"Sunshine Silver Mining & Refining Co"},"owners":[{"id":40605,"kind":"organization","name":"Ospraie Real Assets Fund LP","position":1,"cik":"0001983637","reported_name":"Ospraie Real Assets Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40606,"kind":"organization","name":"Ospraie Real Assets GP LLC","position":2,"cik":"0002126039","reported_name":"Ospraie Real Assets GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":3,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":4,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":5,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":6,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2026-06-08T23:58:44.000Z","date":"2026-06-05","kind":"sale","planned":false,"acquired":false,"shares":555555,"price":13.5,"value":7499992.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 5, 2026, in connection with the closing by Sunshine Silver Mining & Refining Company (the \"Issuer\") of the initial public offering of its common stock (the \"IPO\"), a warrant to purchase 2,615,060 shares of the common stock of the Issuer (the \"Warrant\"), exercisable at $2.87 per share, held by Ospraie Real Assets Fund LP (\"ORA Fund\"), was automatically exercised on a cashless basis, resulting in the Issuer withholding 555,555 of the warrant shares to pay the exercise price and issuing to ORA Fund the remaining 2,059,505 shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Warrant was outstanding as of the date of the Issuer's prospectus (the \"Prospectus\") relating to the IPO as disclosed in the Prospectus. This filing solely relates to the cashless exercise of the Warrant, which was effected solely by the surrender to the Issuer of shares of the Issuer's common stock issuable upon exercise of the Warrant and the Issuer's cancellation thereof to pay the exercise price of the Warrant. No shares of the Issuer's common stock were sold by the reporting person(s) and the shares issued to ORA Fund upon the cashless exercise of the Warrant remain subject to the lock-up agreement that was entered into by ORA Fund in connection with the IPO and disclosed in the Prospectus."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Ospraie Management, LLC (\"OM LLC\") is the investment manager of ORA Fund and has been delegated voting and investment power and thus beneficial ownership of the securities of the Issuer held by ORA Fund. Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the securities of the Issuer held by ORA Fund as the managing member of OM LLC. Ospraie Management, Inc. (\"OM Inc.\") may be deemed to beneficially own the securities of the Issuer held by ORA Fund as the general partner of Ospraie Holding."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Ospraie Real Assets GP LLC (\"Ospraie GP\") may be deemed to beneficially own the securities of the Issuer held by ORA Fund as the general partner of ORA Fund. Dwight Anderson may be deemed to beneficially own the securities of the Issuer held by ORA Fund as the managing member of Ospraie GP and as the sole owner of OM Inc. Each reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":24758995,"source":{"system":"sec-edgar","filing":"0001213900-26-066476","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2091017/000121390026066476/ownership.xml","form_type":"4"}},{"id":746621,"issuer":{"id":4369,"kind":"organization","name":"Sunshine Silver Mining & Refining Co"},"owners":[{"id":40605,"kind":"organization","name":"Ospraie Real Assets Fund LP","position":1,"cik":"0001983637","reported_name":"Ospraie Real Assets Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40606,"kind":"organization","name":"Ospraie Real Assets GP LLC","position":2,"cik":"0002126039","reported_name":"Ospraie Real Assets GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":3,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":4,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":5,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":6,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2026-06-08T23:58:44.000Z","date":"2026-06-05","kind":"other","planned":false,"acquired":true,"shares":2615060,"price":2.87,"value":7505222.2,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Ospraie Management, LLC (\"OM LLC\") is the investment manager of ORA Fund and has been delegated voting and investment power and thus beneficial ownership of the securities of the Issuer held by ORA Fund. Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the securities of the Issuer held by ORA Fund as the managing member of OM LLC. Ospraie Management, Inc. (\"OM Inc.\") may be deemed to beneficially own the securities of the Issuer held by ORA Fund as the general partner of Ospraie Holding."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Ospraie Real Assets GP LLC (\"Ospraie GP\") may be deemed to beneficially own the securities of the Issuer held by ORA Fund as the general partner of ORA Fund. Dwight Anderson may be deemed to beneficially own the securities of the Issuer held by ORA Fund as the managing member of Ospraie GP and as the sole owner of OM Inc. Each reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":25314550,"source":{"system":"sec-edgar","filing":"0001213900-26-066476","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2091017/000121390026066476/ownership.xml","form_type":"4"}},{"id":806933,"issuer":{"id":28525,"kind":"organization","name":"Ionetix Corp / DE /","symbol":"NONE"},"owners":[{"id":40605,"kind":"organization","name":"Ospraie Real Assets Fund LP","position":1,"cik":"0001983637","reported_name":"Ospraie Real Assets Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40606,"kind":"organization","name":"Ospraie Real Assets GP LLC","position":2,"cik":"0002126039","reported_name":"Ospraie Real Assets GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":3,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":4,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":5,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":6,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2026-04-17T01:09:20.000Z","date":"2026-04-09","kind":"other","planned":false,"acquired":true,"shares":3230558,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in the Merger in exchange for a warrant to purchase 6,443,076 shares of Target common stock at an exercise price of $0.01 per share. This warrant contains a provision that restricts the ability of the holder to exercise the warrant to the extent that, after giving effect to the issuance of shares of the common stock of the Issuer upon such exercise, the holder would beneficially own in excess of 19.9% of the number of outstanding shares of the Issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Ospraie Management, LLC (\"OM LLC\") is the investment manager of Ospraie Real Assets Fund LP (\"ORA Fund\") and has been delegated voting and investment power and thus beneficial ownership of the securities of the Issuer held by ORA Fund (such securities, the \"Issuer Securities\"). Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the Issuer Securities as the managing member of OM LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Ospraie Management, Inc. (\"OM Inc.\") may be deemed to beneficially own the Issuer Securities as the general partner of Ospraie Holding. Ospraie Real Assets GP LLC (\"Ospraie GP\") may be deemed to beneficially own the Issuer Securities as the general partner of ORA Fund. Dwight Anderson may be deemed to beneficially own the Issuer Securities as the managing member of Ospraie GP and as the sole owner of OM Inc. Each reporting person disclaims beneficial ownership of the Issuer Securities except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":3230558,"derivative":{"exercise_price":0.02,"exercise_date":"2026-04-09","expiration_date":"2036-04-09","underlying":"Common Stock","underlying_shares":3230558},"source":{"system":"sec-edgar","filing":"0001213900-26-044849","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1326533/000121390026044849/ownership.xml","form_type":"4"}},{"id":806932,"issuer":{"id":28525,"kind":"organization","name":"Ionetix Corp / DE /","symbol":"NONE"},"owners":[{"id":40605,"kind":"organization","name":"Ospraie Real Assets Fund LP","position":1,"cik":"0001983637","reported_name":"Ospraie Real Assets Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40606,"kind":"organization","name":"Ospraie Real Assets GP LLC","position":2,"cik":"0002126039","reported_name":"Ospraie Real Assets GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":3,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":4,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":5,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":6,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2026-04-17T01:09:20.000Z","date":"2026-04-09","kind":"other","planned":false,"acquired":true,"shares":537752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in the Merger in exchange for a warrant to purchase 1,072,500 shares of Target common stock at an exercise price of $1.40 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Ospraie Management, LLC (\"OM LLC\") is the investment manager of Ospraie Real Assets Fund LP (\"ORA Fund\") and has been delegated voting and investment power and thus beneficial ownership of the securities of the Issuer held by ORA Fund (such securities, the \"Issuer Securities\"). Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the Issuer Securities as the managing member of OM LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Ospraie Management, Inc. (\"OM Inc.\") may be deemed to beneficially own the Issuer Securities as the general partner of Ospraie Holding. Ospraie Real Assets GP LLC (\"Ospraie GP\") may be deemed to beneficially own the Issuer Securities as the general partner of ORA Fund. Dwight Anderson may be deemed to beneficially own the Issuer Securities as the managing member of Ospraie GP and as the sole owner of OM Inc. Each reporting person disclaims beneficial ownership of the Issuer Securities except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":537752,"derivative":{"exercise_price":2.79,"exercise_date":"2026-04-09","expiration_date":"2030-04-27","underlying":"Common Stock","underlying_shares":537752},"source":{"system":"sec-edgar","filing":"0001213900-26-044849","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326533/000121390026044849/ownership.xml","form_type":"4"}},{"id":806931,"issuer":{"id":28525,"kind":"organization","name":"Ionetix Corp / DE /","symbol":"NONE"},"owners":[{"id":40605,"kind":"organization","name":"Ospraie Real Assets Fund LP","position":1,"cik":"0001983637","reported_name":"Ospraie Real Assets Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40606,"kind":"organization","name":"Ospraie Real Assets GP LLC","position":2,"cik":"0002126039","reported_name":"Ospraie Real Assets GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":3,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":4,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":5,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":6,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2026-04-17T01:09:20.000Z","date":"2026-04-09","kind":"other","planned":false,"acquired":true,"shares":1316175,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in the Merger in exchange for a warrant to purchase 2,625,000 shares of Target common stock at an exercise price of $1.40 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Ospraie Management, LLC (\"OM LLC\") is the investment manager of Ospraie Real Assets Fund LP (\"ORA Fund\") and has been delegated voting and investment power and thus beneficial ownership of the securities of the Issuer held by ORA Fund (such securities, the \"Issuer Securities\"). Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the Issuer Securities as the managing member of OM LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Ospraie Management, Inc. (\"OM Inc.\") may be deemed to beneficially own the Issuer Securities as the general partner of Ospraie Holding. Ospraie Real Assets GP LLC (\"Ospraie GP\") may be deemed to beneficially own the Issuer Securities as the general partner of ORA Fund. Dwight Anderson may be deemed to beneficially own the Issuer Securities as the managing member of Ospraie GP and as the sole owner of OM Inc. Each reporting person disclaims beneficial ownership of the Issuer Securities except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":1316175,"derivative":{"exercise_price":2.79,"exercise_date":"2026-04-09","expiration_date":"2028-12-14","underlying":"Common Stock","underlying_shares":1316175},"source":{"system":"sec-edgar","filing":"0001213900-26-044849","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326533/000121390026044849/ownership.xml","form_type":"4"}},{"id":806930,"issuer":{"id":28525,"kind":"organization","name":"Ionetix Corp / DE /","symbol":"NONE"},"owners":[{"id":40605,"kind":"organization","name":"Ospraie Real Assets Fund LP","position":1,"cik":"0001983637","reported_name":"Ospraie Real Assets Fund LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40606,"kind":"organization","name":"Ospraie Real Assets GP LLC","position":2,"cik":"0002126039","reported_name":"Ospraie Real Assets GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":3,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":4,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":5,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":6,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-04-17T01:09:20.000Z","date":"2026-04-09","kind":"other","planned":false,"acquired":true,"shares":18206346,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 36,311,022 shares of the common stock of Ionetix Corporation, a privately held Delaware corporation (\"Target\"), in connection with the merger (such transaction, the \"Merger\") of JDEV Merger Subsidiary Corp. (\"Merger Sub\"), a wholly-owned subsidiary of JDEV Acquisition Corp. (such entity, which changed its name to Ionetix Corporation in connection with the Merger, the \"Issuer\"), with and into Target, pursuant to that certain Agreement and Plan of Merger and Reorganization dated as of April 9, 2026 by and among the Issuer, Target and Merger Sub."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Ospraie Management, LLC (\"OM LLC\") is the investment manager of Ospraie Real Assets Fund LP (\"ORA Fund\") and has been delegated voting and investment power and thus beneficial ownership of the securities of the Issuer held by ORA Fund (such securities, the \"Issuer Securities\"). Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the Issuer Securities as the managing member of OM LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Ospraie Management, Inc. (\"OM Inc.\") may be deemed to beneficially own the Issuer Securities as the general partner of Ospraie Holding. Ospraie Real Assets GP LLC (\"Ospraie GP\") may be deemed to beneficially own the Issuer Securities as the general partner of ORA Fund. Dwight Anderson may be deemed to beneficially own the Issuer Securities as the managing member of Ospraie GP and as the sole owner of OM Inc. Each reporting person disclaims beneficial ownership of the Issuer Securities except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":18206346,"source":{"system":"sec-edgar","filing":"0001213900-26-044849","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326533/000121390026044849/ownership.xml","form_type":"4"}},{"id":2206898,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":3,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":4,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":5,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Common Stock, $0.00001 par value","published_at":"2022-07-15T09:09:02.000Z","date":"2022-07-12","kind":"other","acquired":false,"shares":70836258,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger dated March 16, 2022 by and among the Issuer, Bioceres Crop Solutions Corp. and BCS Merger Sub, Inc. (the \"Merger Agreement\") in exchange for 6,233,590 ordinary shares of Bioceres Crop Solutions Corp. having a market value of $9.44 per share at closing on the effective date of the merger."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie Ag Science LLC (\"Ospraie LLC\") and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer held by Ospraie LLC. Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding. OAS MM, LLC may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie LLC. Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and sole managing member of OAS MM, LLC. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-22-039487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000121390022039487/ownership.xml","form_type":"4"}},{"id":2465843,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2021-12-17T16:10:07.000Z","date":"2021-12-15","kind":"exercise","acquired":false,"shares":3553583,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 15, 2021, Ospraie Ag Science LLC (\"Ospraie LLC\") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the \"Issuer\") and purchased the 3,553,583 shares of Issuer Common Stock underlying such warrants."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F3","text":"(Continued from Footnot 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 15, 2021, Ospraie Ag Science LLC (\"Ospraie LLC\") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the \"Issuer\") and purchased the 3,553,583 shares of Issuer Common Stock underlying such warrants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnot 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2020-04-29","expiration_date":"2021-12-15","underlying":"Common Stock","underlying_shares":3553583},"source":{"system":"sec-edgar","filing":"0000899243-21-048765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924321048765/doc4.xml","form_type":"4"}},{"id":2465842,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, $0.00001 par value","published_at":"2021-12-17T16:10:07.000Z","date":"2021-12-15","kind":"exercise","acquired":true,"shares":3553583,"price":0.75,"value":2665187.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 15, 2021, Ospraie Ag Science LLC (\"Ospraie LLC\") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the \"Issuer\") and purchased the 3,553,583 shares of Issuer Common Stock underlying such warrants."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F3","text":"(Continued from Footnot 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":70836258,"source":{"system":"sec-edgar","filing":"0000899243-21-048765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924321048765/doc4.xml","form_type":"4"}},{"id":2786069,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2021-03-16T11:51:19.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":4264299,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 15, 2021, Ospraie Ag Science LLC (\"Ospraie LLC\") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the \"Issuer\") and purchased the 4,264,299 shares of Issuer Common Stock underlying such warrants."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F3","text":"(continued from footnote 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 15, 2021, Ospraie Ag Science LLC (\"Ospraie LLC\") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the \"Issuer\") and purchased the 4,264,299 shares of Issuer Common Stock underlying such warrants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(continued from footnote 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2020-04-29","expiration_date":"2021-03-15","underlying":"Common Stock","underlying_shares":4264299},"source":{"system":"sec-edgar","filing":"0000899243-21-011876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924321011876/doc4.xml","form_type":"4"}},{"id":2786068,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, $0.00001 par value","published_at":"2021-03-16T11:51:19.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":4264299,"price":0.75,"value":3198224.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 15, 2021, Ospraie Ag Science LLC (\"Ospraie LLC\") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the \"Issuer\") and purchased the 4,264,299 shares of Issuer Common Stock underlying such warrants."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F3","text":"(continued from footnote 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":67282675,"source":{"system":"sec-edgar","filing":"0000899243-21-011876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924321011876/doc4.xml","form_type":"4"}},{"id":2939995,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-12-17T14:39:53.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":9476221,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 15, 2020, Ospraie Ag Science LLC (\"Ospraie LLC\") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the \"Issuer\") and purchased the 9,476,221 shares of Issuer Common Stock underlying such warrants."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F3","text":"(Continued from footnote 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 15, 2020, Ospraie Ag Science LLC (\"Ospraie LLC\") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the \"Issuer\") and purchased the 9,476,221 shares of Issuer Common Stock underlying such warrants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from footnote 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2020-04-29","expiration_date":"2020-12-15","underlying":"Common Stock","underlying_shares":9476221},"source":{"system":"sec-edgar","filing":"0000899243-20-034269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320034269/doc4.xml","form_type":"4"}},{"id":2939994,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, $0.00001 par value","published_at":"2020-12-17T14:39:53.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":9476221,"price":0.75,"value":7107165.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 15, 2020, Ospraie Ag Science LLC (\"Ospraie LLC\") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the \"Issuer\") and purchased the 9,476,221 shares of Issuer Common Stock underlying such warrants."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F3","text":"(Continued from footnote 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":63018376,"source":{"system":"sec-edgar","filing":"0000899243-20-034269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320034269/doc4.xml","form_type":"4"}},{"id":3008119,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-10-13T16:25:00.000Z","date":"2020-09-15","kind":"exercise","acquired":false,"shares":1974213,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 15, 2020, Ospraie Ag Science LLC (\"Ospraie LLC\") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the \"Issuer\") and purchased the 1,974,213 shares of Issuer Common Stock underlying such warrants."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F3","text":"(Continued from footnote 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 15, 2020, Ospraie Ag Science LLC (\"Ospraie LLC\") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the \"Issuer\") and purchased the 1,974,213 shares of Issuer Common Stock underlying such warrants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from footnote 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2020-04-29","expiration_date":"2020-09-15","underlying":"Common Stock","underlying_shares":1974213},"source":{"system":"sec-edgar","filing":"0000899243-20-028006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320028006/doc4.xml","form_type":"4"}},{"id":3008118,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, $0.00001 par value","published_at":"2020-10-13T16:25:00.000Z","date":"2020-09-15","kind":"exercise","acquired":true,"shares":1974213,"price":0.75,"value":1480659.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 15, 2020, Ospraie Ag Science LLC (\"Ospraie LLC\") exercised warrants to purchase Common Stock of Marrone Bio Innovations, Inc. (the \"Issuer\") and purchased the 1,974,213 shares of Issuer Common Stock underlying such warrants."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F3","text":"(Continued from footnote 2) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":53542155,"source":{"system":"sec-edgar","filing":"0000899243-20-028006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320028006/doc4.xml","form_type":"4"}},{"id":3165330,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-05-01T17:11:55.000Z","date":"2020-05-01","kind":"exercise","acquired":false,"shares":2467766,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2020-04-29","expiration_date":"2020-05-01","underlying":"Common Stock","underlying_shares":2467766},"source":{"system":"sec-edgar","filing":"0000899243-20-011723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320011723/doc4.xml","form_type":"4"}},{"id":3165329,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-05-01T17:11:55.000Z","date":"2020-04-29","kind":"grant","acquired":true,"shares":3553583,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":3553583,"derivative":{"exercise_price":0.75,"exercise_date":"2020-04-29","expiration_date":"2021-12-15","underlying":"Common Stock","underlying_shares":3553583},"source":{"system":"sec-edgar","filing":"0000899243-20-011723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320011723/doc4.xml","form_type":"4"}},{"id":3165328,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-05-01T17:11:55.000Z","date":"2020-04-29","kind":"grant","acquired":true,"shares":4264299,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":4264299,"derivative":{"exercise_price":0.75,"exercise_date":"2020-04-29","expiration_date":"2021-03-15","underlying":"Common Stock","underlying_shares":4264299},"source":{"system":"sec-edgar","filing":"0000899243-20-011723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320011723/doc4.xml","form_type":"4"}},{"id":3165327,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-05-01T17:11:55.000Z","date":"2020-04-29","kind":"grant","acquired":true,"shares":9476221,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":9476221,"derivative":{"exercise_price":0.75,"exercise_date":"2020-04-29","expiration_date":"2020-12-15","underlying":"Common Stock","underlying_shares":9476221},"source":{"system":"sec-edgar","filing":"0000899243-20-011723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320011723/doc4.xml","form_type":"4"}},{"id":3165326,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-05-01T17:11:55.000Z","date":"2020-04-29","kind":"grant","acquired":true,"shares":1974213,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":1974213,"derivative":{"exercise_price":0.75,"exercise_date":"2020-04-29","expiration_date":"2020-09-15","underlying":"Common Stock","underlying_shares":1974213},"source":{"system":"sec-edgar","filing":"0000899243-20-011723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320011723/doc4.xml","form_type":"4"}},{"id":3165325,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-05-01T17:11:55.000Z","date":"2020-04-29","kind":"grant","acquired":true,"shares":2467766,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":2467766,"derivative":{"exercise_price":0.75,"exercise_date":"2020-04-29","expiration_date":"2020-05-01","underlying":"Common Stock","underlying_shares":2467766},"source":{"system":"sec-edgar","filing":"0000899243-20-011723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320011723/doc4.xml","form_type":"4"}},{"id":3165324,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-05-01T17:11:55.000Z","date":"2020-04-29","kind":"disposition_to_issuer","acquired":false,"shares":5027325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement pursuant to which the Issuer had a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right was in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (the \"Reorganization Agreement Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such Reorganization Warrants were first exercisable 180 days after issuance, had a term expiring on January 1, 2023 and had an exercise price of $1.75 per share."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2023-01-01","underlying":"Common Stock","underlying_shares":5027325},"source":{"system":"sec-edgar","filing":"0000899243-20-011723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320011723/doc4.xml","form_type":"4"}},{"id":3165323,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-05-01T17:11:55.000Z","date":"2020-04-29","kind":"disposition_to_issuer","acquired":false,"shares":1675771,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement pursuant to which the Issuer had a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right was in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (the \"Reorganization Agreement Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such Reorganization Warrants were first exercisable 180 days after issuance, had a term expiring on January 1, 2023 and had an exercise price of $1.75 per share."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2023-01-01","underlying":"Common Stock","underlying_shares":1675771},"source":{"system":"sec-edgar","filing":"0000899243-20-011723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320011723/doc4.xml","form_type":"4"}},{"id":3165322,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-05-01T17:11:55.000Z","date":"2020-04-29","kind":"disposition_to_issuer","acquired":false,"shares":3351542,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement pursuant to which the Issuer had a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right was in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (the \"Reorganization Agreement Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such Reorganization Warrants were first exercisable 180 days after issuance, had a term expiring on January 1, 2023 and had an exercise price of $1.75 per share."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2023-01-01","underlying":"Common Stock","underlying_shares":3351542},"source":{"system":"sec-edgar","filing":"0000899243-20-011723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320011723/doc4.xml","form_type":"4"}},{"id":3165321,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-05-01T17:11:55.000Z","date":"2020-04-29","kind":"disposition_to_issuer","acquired":false,"shares":8378871,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement pursuant to which the Issuer had a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right was in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (the \"Reorganization Agreement Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such Reorganization Warrants were first exercisable 180 days after issuance, had a term expiring on January 1, 2023 and had an exercise price of $1.75 per share."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2023-01-01","underlying":"Common Stock","underlying_shares":8378871},"source":{"system":"sec-edgar","filing":"0000899243-20-011723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320011723/doc4.xml","form_type":"4"}},{"id":3165320,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Warrant","published_at":"2020-05-01T17:11:55.000Z","date":"2020-04-29","kind":"disposition_to_issuer","acquired":false,"shares":12233158,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement pursuant to which the Issuer had a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right was in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (the \"Reorganization Agreement Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such Reorganization Warrants were first exercisable 180 days after issuance, had a term expiring on January 1, 2023 and had an exercise price of $1.75 per share."}],"balance_after":0,"derivative":{"exercise_price":1,"expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":12233158},"source":{"system":"sec-edgar","filing":"0000899243-20-011723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320011723/doc4.xml","form_type":"4"}},{"id":3165319,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock, $0.00001 par value","published_at":"2020-05-01T17:11:55.000Z","date":"2020-05-01","kind":"exercise","acquired":true,"shares":2467766,"price":0.75,"value":1850824.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2020, Marrone Bio Innovations, Inc. (the \"Issuer\") entered into a Warrant Exchange Agreement (the \"Warrant Exchange Agreement\") with Ospraie Ag Science LLC (\"Ospraie LLC\"), Ardsley Partners Renewable Energy Fund, L.P., National Securities Corporation, Ivan Saval, Ivy Science & Technology Fund and Ivy VIP Science & Technology, pursuant to which Ospraie LLC exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants (\"New Warrants\") to purchase Common Stock of the Issuer, totaling 21,736,082 New Warrants in the aggregate.  Each New Warrant received by Ospraie LLC from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75 per share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Pursuant to the Warrant Exchange Agreement, Ospraie LLC agreed to exercise the first tranche of New Warrants on or before May 1, 2020.  Ospraie LLC exercised such first tranche of New Warrants on May 1, 2020, and purchased 2,467,766 shares of Issuer Common Stock.  The transactions pursuant to the Warrant Exchange Agreement were approved in advance by the Issuer's Board of Directors."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and New Warrants held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."}],"balance_after":51567942,"source":{"system":"sec-edgar","filing":"0000899243-20-011723","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320011723/doc4.xml","form_type":"4"}},{"id":3222493,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Warrant","published_at":"2020-03-06T15:01:09.000Z","date":"2020-03-04","kind":"exercise","acquired":true,"shares":5027325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities of Marrone Bio Innovations, Inc. (the \"Issuer\") are or were held by Ospraie Ag Science LLC (\"Ospraie LLC\"). Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding.  Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from Footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On March 4, 2020, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 5,027,325 warrants into shares of Common Stock and New Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On March 4, 2020, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 5,027,325 warrants into shares of Common Stock and New Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On March 4, 2020, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 5,027,325 warrants into shares of Common Stock and New Warrants."}],"balance_after":5027325,"derivative":{"exercise_price":1.75,"expiration_date":"2023-01-01","underlying":"Common Stock","underlying_shares":5027325},"source":{"system":"sec-edgar","filing":"0000899243-20-007399","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320007399/doc4.xml","form_type":"4"}},{"id":3222492,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Warrant","published_at":"2020-03-06T15:01:09.000Z","date":"2020-03-04","kind":"exercise","acquired":false,"shares":5027325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities of Marrone Bio Innovations, Inc. (the \"Issuer\") are or were held by Ospraie Ag Science LLC (\"Ospraie LLC\"). Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding.  Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from Footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On March 4, 2020, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 5,027,325 warrants into shares of Common Stock and New Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On March 4, 2020, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 5,027,325 warrants into shares of Common Stock and New Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On March 4, 2020, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 5,027,325 warrants into shares of Common Stock and New Warrants."}],"balance_after":12233158,"derivative":{"exercise_price":1,"expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":5027325},"source":{"system":"sec-edgar","filing":"0000899243-20-007399","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320007399/doc4.xml","form_type":"4"}},{"id":3222491,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Common Stock, $0.00001 par value","published_at":"2020-03-06T15:01:09.000Z","date":"2020-03-04","kind":"exercise","acquired":true,"shares":5027325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities of Marrone Bio Innovations, Inc. (the \"Issuer\") are or were held by Ospraie Ag Science LLC (\"Ospraie LLC\"). Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding.  Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from Footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On March 4, 2020, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 5,027,325 warrants into shares of Common Stock and New Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On March 4, 2020, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 5,027,325 warrants into shares of Common Stock and New Warrants."}],"balance_after":49100176,"source":{"system":"sec-edgar","filing":"0000899243-20-007399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320007399/doc4.xml","form_type":"4"}},{"id":3327068,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Warrant","published_at":"2020-01-02T15:19:02.000Z","date":"2019-12-30","kind":"exercise","acquired":true,"shares":1675771,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities of Marrone Bio Innovations, Inc. (the \"Issuer\") are or were held by Ospraie Ag Science LLC (\"Ospraie LLC\"). Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from Footnote 3) On December 30, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 1,675,771 warrants into shares of Common Stock and New Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) On December 30, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 1,675,771 warrants into shares of Common Stock and New Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) On December 30, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 1,675,771 warrants into shares of Common Stock and New Warrants."}],"balance_after":1675771,"derivative":{"exercise_price":1.75,"expiration_date":"2023-01-01","underlying":"Common Stock","underlying_shares":1675771},"source":{"system":"sec-edgar","filing":"0000899243-20-000043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320000043/doc4.xml","form_type":"4"}},{"id":3327067,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Warrant","published_at":"2020-01-02T15:19:02.000Z","date":"2019-12-30","kind":"exercise","acquired":false,"shares":1675771,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities of Marrone Bio Innovations, Inc. (the \"Issuer\") are or were held by Ospraie Ag Science LLC (\"Ospraie LLC\"). Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from Footnote 3) On December 30, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 1,675,771 warrants into shares of Common Stock and New Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) On December 30, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 1,675,771 warrants into shares of Common Stock and New Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) On December 30, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 1,675,771 warrants into shares of Common Stock and New Warrants."}],"balance_after":17260483,"derivative":{"exercise_price":1,"expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":1675771},"source":{"system":"sec-edgar","filing":"0000899243-20-000043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320000043/doc4.xml","form_type":"4"}},{"id":3327066,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Common Stock, $0.00001 par value","published_at":"2020-01-02T15:19:02.000Z","date":"2019-12-30","kind":"exercise","acquired":true,"shares":1675771,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities of Marrone Bio Innovations, Inc. (the \"Issuer\") are or were held by Ospraie Ag Science LLC (\"Ospraie LLC\"). Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from Footnote 3) On December 30, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 1,675,771 warrants into shares of Common Stock and New Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised.  Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) On December 30, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 1,675,771 warrants into shares of Common Stock and New Warrants."}],"balance_after":44072851,"source":{"system":"sec-edgar","filing":"0000899243-20-000043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924320000043/doc4.xml","form_type":"4"}},{"id":3333829,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Warrant","published_at":"2019-12-20T15:04:16.000Z","date":"2019-12-18","kind":"exercise","acquired":true,"shares":3351542,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities of Marrone Bio Innovations, Inc. (the \"Issuer\") are or were held by Ospraie Ag Science LLC (\"Ospraie LLC\"). Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On December 18, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 3,351,542 warrants into shares of Common Stock and New Warrants"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On December 18, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 3,351,542 warrants into shares of Common Stock and New Warrants"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On December 18, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 3,351,542 warrants into shares of Common Stock and New Warrants"}],"balance_after":3351542,"derivative":{"exercise_price":1.75,"expiration_date":"2023-01-01","underlying":"Common Stock","underlying_shares":3351542},"source":{"system":"sec-edgar","filing":"0000899243-19-029736","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924319029736/doc4.xml","form_type":"4"}},{"id":3333828,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Warrant","published_at":"2019-12-20T15:04:16.000Z","date":"2019-12-18","kind":"exercise","acquired":false,"shares":3351542,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities of Marrone Bio Innovations, Inc. (the \"Issuer\") are or were held by Ospraie Ag Science LLC (\"Ospraie LLC\"). Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On December 18, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 3,351,542 warrants into shares of Common Stock and New Warrants"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On December 18, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 3,351,542 warrants into shares of Common Stock and New Warrants"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On December 18, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 3,351,542 warrants into shares of Common Stock and New Warrants"}],"balance_after":18936254,"derivative":{"exercise_price":1,"expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":3351542},"source":{"system":"sec-edgar","filing":"0000899243-19-029736","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924319029736/doc4.xml","form_type":"4"}},{"id":3333827,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Common Stock, $0.00001 par value","published_at":"2019-12-20T15:04:16.000Z","date":"2019-12-18","kind":"exercise","acquired":true,"shares":3351542,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities of Marrone Bio Innovations, Inc. (the \"Issuer\") are or were held by Ospraie Ag Science LLC (\"Ospraie LLC\"). Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On December 18, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 3,351,542 warrants into shares of Common Stock and New Warrants"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's Common Stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On December 18, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised 3,351,542 warrants into shares of Common Stock and New Warrants"}],"balance_after":42397080,"source":{"system":"sec-edgar","filing":"0000899243-19-029736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924319029736/doc4.xml","form_type":"4"}},{"id":3421731,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Warrant","published_at":"2019-09-05T17:41:55.000Z","date":"2019-09-04","kind":"exercise","acquired":true,"shares":8378871,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities of Marrone Bio Innovations, Inc. (the \"Issuer\") are or were held by Ospraie Ag Science LLC (\"Ospraie LLC\"). Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On September 4, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise a portion of its warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised the 8,378,871 warrants covered by the Issuer's notice into shares of Common Stock and New Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On September 4, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise a portion of its warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised the 8,378,871 warrants covered by the Issuer's notice into shares of Common Stock and New Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On September 4, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise a portion of its warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised the 8,378,871 warrants covered by the Issuer's notice into shares of Common Stock and New Warrants."}],"balance_after":8378871,"derivative":{"exercise_price":1.75,"expiration_date":"2023-01-01","underlying":"Common Stock","underlying_shares":8378871},"source":{"system":"sec-edgar","filing":"0000899243-19-022863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924319022863/doc4.xml","form_type":"4"}},{"id":3421730,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Warrant","published_at":"2019-09-05T17:41:55.000Z","date":"2019-09-04","kind":"exercise","acquired":false,"shares":8378871,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities of Marrone Bio Innovations, Inc. (the \"Issuer\") are or were held by Ospraie Ag Science LLC (\"Ospraie LLC\"). Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On September 4, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise a portion of its warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised the 8,378,871 warrants covered by the Issuer's notice into shares of Common Stock and New Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On September 4, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise a portion of its warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised the 8,378,871 warrants covered by the Issuer's notice into shares of Common Stock and New Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On September 4, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise a portion of its warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised the 8,378,871 warrants covered by the Issuer's notice into shares of Common Stock and New Warrants."}],"balance_after":22287796,"derivative":{"exercise_price":1,"expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":8378871},"source":{"system":"sec-edgar","filing":"0000899243-19-022863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924319022863/doc4.xml","form_type":"4"}},{"id":3421729,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":125355,"kind":"person","name":"Ospraie Ag Science LLC","position":1,"cik":"0001730557","reported_name":"Ospraie Ag Science LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40607,"kind":"organization","name":"Ospraie Management, LLC","position":2,"cik":"0001326533","reported_name":"Ospraie Management, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40608,"kind":"organization","name":"Ospraie Holding I, L.P.","position":3,"cik":"0001392205","reported_name":"Ospraie Holding I, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40609,"kind":"organization","name":"Ospraie Management, Inc.","position":4,"cik":"0001392203","reported_name":"Ospraie Management, Inc.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}},{"id":40610,"kind":"person","name":"Anderson Dwight","position":5,"cik":"0001392202","reported_name":"Anderson Dwight","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"(See Remarks)"}}],"security":"Common Stock, $0.00001 par value","published_at":"2019-09-05T17:41:55.000Z","date":"2019-09-04","kind":"exercise","acquired":true,"shares":8378871,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities of Marrone Bio Innovations, Inc. (the \"Issuer\") are or were held by Ospraie Ag Science LLC (\"Ospraie LLC\"). Ospraie Management, LLC (\"Ospraie Management\") is the investment manager of Ospraie LLC and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC.  Ospraie Holding I, LP (\"Ospraie Holding\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. (\"Ospraie Inc.\") may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer and warrants to purchase shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and the sole managing member of Ospraie LLC.  Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any."},{"field":"kind","element":"transactionCoding","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On September 4, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise a portion of its warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised the 8,378,871 warrants covered by the Issuer's notice into shares of Common Stock and New Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"As previously disclosed, on August 6, 2019, the Issuer, Ospraie LLC, Ardsley Partners Renewable Energy Fund, L.P. and Ivan Saval entered into a Warrant Amendment and Plan of Reorganization Agreement (the \"Agreement\") pursuant to which the Issuer has a right, so long as the closing price for the Issuer's common stock on its principal market immediately prior to the exercise of such right is in excess of the exercise price for the warrants, to require Ospraie LLC to exercise up to all of its warrants in exchange for the shares of Common Stock underlying such warrants and new warrants (\"New Warrants\") to purchase shares of Common Stock of the Issuer in an amount equal to the amount of warrants being required to be exercised."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) Such New Warrants will be first exercisable 180 days after issuance, will have a term expiring on January 1, 2023 and will have an exercise price of $1.75 per share.  On September 4, 2019, following receipt of notice from the Issuer that the Issuer was exercising its right pursuant to the Agreement to require Ospraie LLC to exercise a portion of its warrants in exchange for shares of Common Stock of the Issuer and New Warrants, Ospraie LLC exercised the 8,378,871 warrants covered by the Issuer's notice into shares of Common Stock and New Warrants."}],"balance_after":39045538,"source":{"system":"sec-edgar","filing":"0000899243-19-022863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000089924319022863/doc4.xml","form_type":"4"}}]}